The independent source for health policy research, polling, and news.
Former FDA Commissioner Dr. Robert Califf shares his views about drug approvals, regulations and safety concerns after stepping down from the giant agency.
A federal judge in Texas last month issued a preliminary injunction barring the government from enforcing a rule allowing insurers to refuse to insure dialysis patients who get premium assistance from charity groups.
After hearing complaints about its high price, Marathon Pharmaceuticals is pausing the launch of an $89,000 drug for a rare disease.
Taking time to discuss the inevitable can help conquer a universal fear.
More than 6,000 workers had levels in their blood that could lead to heart, kidney or cognitive disease, according to state findings.
In remote parts of Montana, the Affordable Care Act has meant better health care for Native Americans and more job opportunities.
A new report finds that major insurers like Aetna and UnitedHealth submitted conflicting lists to the state that were off by thousands of doctors.
Citing a Kaiser Health News investigation, Senate Judiciary Committee Chairman Chuck Grassley vows to examine the orphan drug program and possible fixes.
A study of five states looks at the market conditions that make or break the health insurance marketplaces set up by the Affordable Care Act.
After a tough fight by Democrats, Senate Republicans confirmed Rep. Tom Price’s nomination to head the Department of Health and Human Services. He will have the authority to upend some current practices.
Lung cancer screening rates have not changed much even though the U.S. Preventive Services Task Force has recommended that smokers get checked, according to a new study.
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
Republicans’ delay in finding common ground to repeal and replace the health law raises risks that coverage could shrink and rates rise even more, the industry says.
New advocacy groups like Indivisible California weigh strategies for long-haul political activism, including protests.
The first overhaul of federal regulations in almost 30 years for home health care agencies will require them to be much more responsive to what aging patients and their caregivers need or want.
In an interview with Kaiser Health News, Michael Botticelli outlines his concerns about how GOP efforts to dismantle the health law’s coverage expansions could jeopardize treatment for people in need.
Remarks by Sen. Mike Lee and Reps. Jim Jordan and Mark Meadows reflect growing uncertainty about Republicans’ path to overhaul Obamacare.
Insurers and care providers say efforts to fix how consumers are notified also raise concerns.
Prescription pain pills are strong sellers in this southeastern Kentucky region that’s long struggled with high rates of joblessness and poor health.
A Harvard health policy expert faced a racing heartbeat and $6,000 deductible on his insurance plan. What did he do?
